Bio-Techne (TECH) Share-based Compensation (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,093.60% |
| Dec 31, 2025 | -95.72% |
| Sep 30, 2025 | 156.75% |
| Jun 30, 2025 | 1,037.50% |
| Mar 31, 2025 | -97.37% |
| Dec 31, 2024 | 49.63% |
| Sep 30, 2024 | 44.19% |
| Jun 30, 2024 | -12.80% |
| Mar 31, 2024 | 2,600.00% |
| Dec 31, 2023 | -97.03% |
| Sep 30, 2023 | 584.08% |
| Jun 30, 2023 | -1,142.50% |
| Mar 31, 2023 | -98.77% |
| Dec 31, 2022 | 12.03% |
| Sep 30, 2022 | 72.03% |
| Jun 30, 2022 | -7.18% |
| Mar 31, 2022 | 2,164.00% |
| Dec 31, 2021 | -96.59% |
| Sep 30, 2021 | -7.38% |
| Jun 30, 2021 | 3,068.00% |
| Mar 31, 2021 | -97.44% |
| Dec 31, 2020 | 20.44% |
| Sep 30, 2020 | 115.27% |
| Jun 30, 2020 | -25.61% |
| Mar 31, 2020 | -23.83% |
| Dec 31, 2019 | 20.66% |
| Sep 30, 2019 | 8.25% |
| Jun 30, 2019 | 41.99% |
| Mar 31, 2019 | -17.03% |
| Dec 31, 2018 | -40.34% |
| Sep 30, 2018 | -21.07% |
| Jun 30, 2018 | 211.77% |
| Mar 31, 2018 | -6.00% |
| Dec 31, 2017 | 31.75% |
| Sep 30, 2017 | 11.23% |
| Jun 30, 2017 | -14.14% |
| Mar 31, 2017 | -3.07% |
| Dec 31, 2016 | 28.53% |
| Sep 30, 2016 | 15.83% |
| Jun 30, 2016 | 18.86% |
| Mar 31, 2016 | -0.17% |
| Dec 31, 2015 | 13.89% |
| Sep 30, 2015 | 65.42% |
| Jun 30, 2015 | -4.35% |
| Mar 31, 2015 | -37.93% |
| Dec 31, 2014 | 52.35% |
| Sep 30, 2014 | 53.38% |
| Jun 30, 2014 | 26.86% |
| Mar 31, 2014 | -46.15% |
| Dec 31, 2013 | 128.47% |
| Sep 30, 2013 | 16.12% |
| Jun 30, 2013 | 71.33% |
| Mar 31, 2013 | -63.57% |
| Dec 31, 2012 | 159.08% |
| Sep 30, 2012 | 20.24% |
| Jun 30, 2012 | 4.56% |
| Mar 31, 2012 | -71.91% |
| Dec 31, 2011 | 195.86% |
| Sep 30, 2011 | 44.28% |
| Jun 30, 2011 | 131.03% |
| Mar 31, 2011 | -87.82% |
| Dec 31, 2010 | 425.00% |
| Sep 30, 2010 | -22.29% |
| Jun 30, 2010 | 116.05% |
| Mar 31, 2010 | -89.58% |
| Dec 31, 2009 | 661.76% |